American Well (NYSE:AMWL) Stock Price Expected to Rise, TD Cowen Analyst Says

Key Points

• TD Cowen raised its American Well price target from $12 to $13 but maintained a Hold rating, implying 4.37% upside from the cited share price.
• Analyst views remain mixed: the consensus rating is Hold with a $12.30 target, while Wells Fargo set a more bullish $18 target and Stifel retained Hold with a $12 target.
• Amwell’s latest quarter beat consensus estimates, reporting $48.99 million in revenue and a per-share loss of $0.67 versus estimates of $47.28 million and $0.78, respectively.

American Well (NYSE:AMWL - Get Free Report) had its target price lifted by equities researchers at TD Cowen from $12.00 to $13.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a "hold" rating on the stock. TD Cowen's price objective suggests a potential upside of 4.37% from the stock's current price.

A number of other equities research analysts have also recently issued reports on AMWL. Truist Financial set a $12.00 target price on shares of American Well and gave the company a "hold" rating in a report on Thursday, August 13th. Weiss Ratings reissued a "sell (d-)" rating on shares of American Well in a research report on Thursday, October 15th. Wells Fargo & Company lifted their target price on American Well from $16.00 to $18.00 and gave the stock an "overweight" rating in a research note on Wednesday. Needham & Company LLC reissued a "hold" rating on shares of American Well in a report on Wednesday, August 5th. Finally, Stifel Nicolaus increased their price target on American Well from $11.00 to $12.00 and gave the company a "hold" rating in a research note on Wednesday. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, American Well has an average rating of "Hold" and a consensus price target of $12.30.

American Well Stock Performance

NYSE AMWL traded down $0.28 during trading hours on Wednesday, hitting $12.46. 113,947 shares of the company traded hands, compared to its average volume of 101,139. The business's 50-day moving average is $12.95 and its 200-day moving average is $8.99. The stock has a market capitalization of $206.15 million, a price-to-earnings ratio of -2.62 and a beta of 1.72. American Well has a twelve month low of $3.71 and a twelve month high of $15.16.

American Well (NYSE:AMWL - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported ($0.67) earnings per share for the quarter, topping the consensus estimate of ($0.78) by $0.11. The firm had revenue of $48.99 million for the quarter, compared to analyst estimates of $47.28 million. American Well had a negative return on equity of 30.12% and a negative net margin of 35.75%. Analysts predict that American Well will post -2.56 EPS for the current year.

Insider Transactions at American Well

In other news, insider Phyllis Gotlib sold 6,677 shares of the business's stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $13.00, for a total transaction of $86,801.00. Following the completion of the sale, the insider owned 142,504 shares in the company, valued at $1,852,552. The trade was a 4.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Dmitry Zamansky sold 8,442 shares of the company's stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $13.00, for a total value of $109,746.00. Following the completion of the transaction, the insider directly owned 224,178 shares in the company, valued at $2,914,314. The trade was a 3.63% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 19,457 shares of company stock worth $248,519. 12.84% of the stock is owned by company insiders.

Institutional Trading of American Well

A hedge fund recently raised its stake in American Well stock. Senvest Management LLC grew its position in shares of American Well Corporation (NYSE:AMWL - Free Report) by 213.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,136,558 shares of the company's stock after buying an additional 773,834 shares during the period. Senvest Management LLC owned approximately 6.87% of American Well worth $5,978,000 at the end of the most recent quarter. Institutional investors own 56.05% of the company's stock.

Key American Well News

Here are the key news stories impacting American Well this week:

• Positive Sentiment: Wells Fargo raised its price target to $18 from $16 and reiterated an Overweight rating, implying about 39% upside from the cited $12.93 share price. Wells Fargo recommendation
• Neutral Sentiment: Amwell reported Q3 revenue of $48.99 million, above analyst expectations of $47.28 million. Its $0.67 per-share loss was narrower than the year-ago loss of $1.74, but estimates differed: it beat MarketBeat’s consensus loss estimate of $0.78, while slightly missing Zacks’ estimate of $0.66. Q3 2026 results Zacks earnings analysis
• Negative Sentiment: Stifel raised its target to $12 from $11 but kept a Hold rating; its target was about 7% below the cited share price, offering a more cautious counterpoint to Wells Fargo’s upgrade. Stifel recommendation

About American Well

American Well, doing business as Amwell, is a digital healthcare company that provides technology and services for virtual care. Its platform connects patients with healthcare professionals through video and other digital channels, supporting services such as urgent care, behavioral health, primary care and specialty consultations.

Amwell primarily serves health systems, health plans, employers and other healthcare organizations. Its offerings include the Amwell Converge platform, which is designed to help organizations develop, manage and integrate digital care programs with existing clinical workflows and healthcare systems.

Founded in 2006 by brothers Ido and Roy Schoenberg, the company was formerly known as American Well and adopted the Amwell brand in 2020.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.